{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:50:30Z","timestamp":1788306630099,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24AI148459"],"award-info":[{"award-number":["K24AI148459"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpeds.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:16:38Z","timestamp":1602292598000},"page":"207-215.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"229","author":[{"given":"Susan C.","family":"Lipsett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-607X","authenticated-orcid":false,"given":"Lilliam","family":"Ambroggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2020.10.005_bib1","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2020.10.005_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1542\/peds.2010-2008","article-title":"Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007","volume":"127","author":"Kronman","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/INF.0b013e31825f2b10","article-title":"Variability in processes of care and outcomes among children hospitalized with community-acquired pneumonia","volume":"31","author":"Brogan","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2020.10.005_bib4","doi-asserted-by":"crossref","first-page":"e20163231","DOI":"10.1542\/peds.2016-3231","article-title":"Impact of a national guideline on antibiotic selection for hospitalized pneumonia","volume":"139","author":"Williams","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40121-019-00276-3","article-title":"Ambulatory antibiotic pprescribing for children with pneumonia after publication of national guidelines: a cross-sectional retrospective study","volume":"9","author":"Poole","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jpeds.2020.10.005_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jpids\/piz026","article-title":"Diagnostic testing and antibiotic use in young children with community-acquired pneumonia in the United States, 2008-2015","volume":"9","author":"Florin","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jpeds.2020.10.005_bib7","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1542\/peds.2013-1614","article-title":"Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia","volume":"132","author":"Williams","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib8","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2017.18715","article-title":"Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections","volume":"318","author":"Gerber","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2020.10.005_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ppul.23312","article-title":"Beta-lactam versus beta- lactam\/macrolide therapy in pediatric outpatient pneumonia","volume":"51","author":"Ambroggio","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jpeds.2020.10.005_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006454-199810000-00004","article-title":"Safety and efficacy of azithromycin in the treatment of community- acquired pneumonia in children","volume":"17","author":"Harris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2020.10.005_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00006454-199902000-00004","article-title":"Etiology and treatment of community-acquired pneumonia in ambulatory children","volume":"18","author":"Wubbel","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2020.10.005_bib12","first-page":"704","volume":"13","author":"Aurangzeb","year":"2003","journal-title":"Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community-acquired pneumonia in children"},{"key":"10.1016\/j.jpeds.2020.10.005_bib13","doi-asserted-by":"crossref","first-page":"e20192816","DOI":"10.1542\/peds.2019-2816","article-title":"Trends in chest radiographs for pneumonia in emergency departments","volume":"145","author":"Geanacopoulos","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib14","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1542\/peds.107.6.e99","article-title":"Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services","volume":"107","author":"Feudtner","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jpeds.2020.10.005_bib18","doi-asserted-by":"crossref","first-page":"e20183090","DOI":"10.1542\/peds.2018-3090","article-title":"Prevalence, risk factors, and outcomes of bacteremic pneumonia in children","volume":"144","author":"Fritz","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jpeds.2015.05.033","article-title":"Glucocorticoids and hospital length of stay for children with anaphylaxis: a retrospective study","volume":"167","author":"Michelson","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2020.10.005_bib20","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamapediatrics.2017.3225","article-title":"Effectiveness of \u03b2-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia","volume":"171","author":"Williams","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2020.10.005_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(15)00500-7","article-title":"Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Stokholm","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jpeds.2020.10.005_bib22","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3201\/eid1411.080386","article-title":"Novel human rhinoviruses and exacerbation of asthma in children","volume":"14","author":"Khetsuriani","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jpeds.2020.10.005_bib23","doi-asserted-by":"crossref","first-page":"e20174105","DOI":"10.1542\/peds.2017-4105","article-title":"Respiratory viruses and treatment failure in children with asthma exacerbation","volume":"142","author":"Merckx","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2020.10.005_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jac\/dkv418","article-title":"The worldwide antibiotic resistance and prescribing in european children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children","volume":"71","author":"Versporten","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpeds.2020.10.005_bib27","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1542\/peds.2013-1773","article-title":"Comparative effectiveness of empiric antibiotics for community-acquired pneumonia","volume":"133","author":"Queen","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2020.10.005_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10156-008-0648-6","article-title":"Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia","volume":"14","author":"Hamano-Hasegawa","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jpeds.2020.10.005_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jpids\/pix083","article-title":"Macrolides in children with community-acquired pneumonia: panacea or placebo?","volume":"7","author":"Blyth","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jpeds.2020.10.005_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/INF.0000000000000740","article-title":"Comparative effectiveness of beta-lactam versus macrolide monotherapy in children with pneumonia diagnosed in the outpatient setting","volume":"34","author":"Ambroggio","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2020.10.005_bib31","first-page":"CD0019554","article-title":"Azithromycin for acute lower respiratory tract infections","volume":"3","author":"Laopaiboon","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2020.10.005_bib32","first-page":"CD004418","article-title":"Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults","volume":"9","author":"Eliakim-Raz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2020.10.005_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2020.10.005_bib34","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jac\/dku033","article-title":"\u03b2-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis","volume":"69","author":"Nie","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpeds.2020.10.005_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00006454-200001000-00009","article-title":"Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae","volume":"19","author":"Morita","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2020.10.005_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jpeds.2020.10.005_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2020.10.005_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-0691.2009.02725.x","article-title":"Antibiotic consumption and link to resistance","volume":"15","author":"Goossens","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jpeds.2020.10.005_bib39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jpeds.2020.10.005_bib40","doi-asserted-by":"crossref","first-page":"154348","DOI":"10.1016\/j.metabol.2020.154348","article-title":"Association of class number, cumulative exposure, and earlier initiation of antibiotics during the first two-years of life with subsequent childhood obesity","volume":"112","author":"Park","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jpeds.2020.10.005_bib41","first-page":"CD009175","article-title":"Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia","volume":"10","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2020.10.005_bib42","doi-asserted-by":"crossref","first-page":"e20180331","DOI":"10.1542\/peds.2018-0331","article-title":"Guideline adoption for community-acquired pneumonia in the outpatient setting","volume":"142","author":"Ambroggio","year":"2018","journal-title":"Pediatrics"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347620312671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347620312671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:23:04Z","timestamp":1777440184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347620312671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":40,"alternative-id":["S0022347620312671"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2020.10.005","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}